GLP-1 medications are FDA-approved and widely studied, but like any treatment, they can have side effects
Safety vigilance, thoughtful patient selection, and integration with behavioural care are the practical requirements for translating trial efficacy into real-world benefit
The tradeoff is a higher rate of GI adverse events
[DOI] [PubMed] [Google Scholar] 2.Boccardi A., Shubrook J.H
People beginning weight loss therapy often report multiple physical sensations as their bodies adjust, making it essential to understand which symptoms are expected and which require urgent attention
Davies M et al (2021) Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial